Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Physical Activity Slows Cognitive Decline in Parkinson’s Disease

Publish date:: July 2, 2019

Key clinical point: Physical activity is associated with slower cognitive decline in patients with de novo Parkinson’s disease.

Major finding: Higher scores on the Physical Activity Scale for the Elderly over time had a significant effect on cognitive function.

Study details: A prospective study of 379 patients enrolled in the Parkinson’s Progression Markers Initiative.

Disclosures: Dr. Mantri had no relevant financial disclosures. Among her coauthors, Dr. Tropea received personal compensation from Genzyme and Medtronics and research support from Sanofi. Dr. Morley had nothing to disclose.

Citation:

Mantri S et al. AAN 2019, Abstract P2.8-021.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients,

Denosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosis,

Treatment sequence with romosozumab influences osteoporosis outcomes,

Must Reads in Neurology

Physical Activity Slows Cognitive Decline in Parkinson’s Disease,

Intensive BP Control & Risk of Dementia, JAMA; ePub 2019 Jan 28; SPRINT MIND Investigators

Health Care Utilization of a Dementia Care Program, JAMA Intern Med; ePub 2018 Dec 21; Jennings, et al

Smoking and Risk of Ischemic Stroke in Young Men, Stroke; ePub 2018 Apr 19; Markidan, et al

Prior Use of NOACs & Mortality in ICH Patients, JAMA; 2018 Feb 6; Inohara, Xian, Liang, et al